— Know what they know.
Not Investment Advice
Also trades as: CGS.AX (ASX) · $vol 1M

COGZF OTC

Cogstate Limited
1W: +10.9% 1M: -2.5% 3M: +30.0% YTD: +46.2% 1Y: +85.7% 3Y: +136.0% 5Y: +38.5%
$2.34
+0.07 (+3.08%)
 
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Buy · Power 63 · $397.6M mcap · 79M float · 0.0031% daily turnover · Short 92% of daily vol

Income Trends

Revenue
$60M +79.7% ▲
5Y CAGR: +6.4%
Gross Profit
$20M +0.6% ▲
5Y CAGR: +14.2%
Operating Income
$12M +74.5% ▲
5Y CAGR: +19.2%
Net Income
$12M +82.7% ▲
5Y CAGR: +11.6%
EPS (Diluted)
$0.07 +79.8% ▲
5Y CAGR: +11.1%
EBITDA
$15M +39.7% ▲
5Y CAGR: +13.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$62M$60M$65M$51M$60M
YoY Growth+41.6%-3.0%+8.3%-22.0%+79.7%
Cost of Revenue$40M$48M$19M$20M$40M
Gross Profit$22M$12M$46M$31M$20M
Gross Margin34.9%20.4%71.2%60.4%33.8%
R&D Expenses$9M$11M$0$0$0
SG&A Expenses$12M$14M$14M$13M$8M
Operating Expenses$7M$9M$19M$20M$8M
Operating Income$15M$3M$6M$11M$12M
Operating Margin24.3%5.7%9.5%21.2%20.6%
Interest Expense$84K$70K$51K$76K$18K
Income Before Tax$15M$4M$11M$14M$16M
Tax Expense$4M-$807K$2M$4M$4M
Net Income$10M$5M$5M$10M$12M
Net Margin16.7%8.8%8.4%20.0%20.3%
EPS (Diluted)$0.06$0.03$0.05$0.06$0.07
EBITDA$18M$8M$10M$17M$15M
Shares Outstanding177M176M173M174M177M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms